Phase 1-2a multicenter dose-escalation study of ezatiostat hydrochloride liposomes for injection (Telintra®, TLK199), a novel glutathione analog prodrug in patients with myelodysplastic syndrome
Open Access
- 13 May 2009
- journal article
- research article
- Published by Springer Science and Business Media LLC in Journal of Hematology & Oncology
- Vol. 2 (1), 20
- https://doi.org/10.1186/1756-8722-2-20
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Clinical application and proposal for modification of the International Working Group (IWG) response criteria in myelodysplasiaBlood, 2006
- Pharmacologic or genetic manipulation of glutathione S-transferase P1-1 (GSTpi) influences cell proliferation pathways.2001
- Report of an international working group to standardize response criteria for myelodysplastic syndromes.2000
- Regulation of JNK signaling by GSTpThe EMBO Journal, 1999
- Increased skin tumorigenesis in mice lacking pi class glutathione S -transferasesProceedings of the National Academy of Sciences, 1998
- Morphology and Classification of Myelodysplastic SyndromesHematology/Oncology Clinics of North America, 1992
- The Classification of Myelodysplastic SyndromesPublished by Springer Science and Business Media LLC ,1992
- Myelodysplastic syndromes: natural history and features of prognostic importance.1986
- Chronic myelodysplastic syndrome: short survival with or without evolution to acute leukaemiaBritish Journal of Haematology, 1983